We have examined the chicken Very Low Density Apolipoprotein 11 (apoVLDL 11) gene locus in transgenic mice. A DNA fragment composed of the transcribed region, 16 kb of 5' flanking and 400 bp of 3' flanking sequences contained all the information sufficient for estrogen-inducible, liver-specific expression of the apoVLDL 11 gene. The far-upstream region contains a Negative Regulating Element coinciding with a DNaselhypersensitive site at -11 kb. In transgenic mice, the NRE at -11 kb is used for downregulating the expression to a lower maximum level. The NRE might be used for modulating apoVLDL 11 gene expression, and may be involved in the rapid shut-down of the expression after hormone removal.
INTRODUCTION
The ability for stimulus-induced tissue-specific gene expression during development and differentiation in higher organisms is preprogrammed. In this way, different cells can use the same stimulus for different expression programs. The stimulus can have an environmental cause like infection, starvation or stress. Alternatively, it can be a molecule involved in intercellular signaling, for example a hormone (1) . The chicken apoVLDL II gene provides an example of a gene which is expressed tissuespecifically and is strictly dependent on a hormone (2) . In this case, the liver is the expressing tissue and estradiol is the inducing hormone. In other tissues, estradiol stimulates the transcription of different genes, for example in chicken oviduct the lysozyme gene is stimulated several-fold (3) . The regulation of the expression of these genes requires the action of trans-acting transcription factors and cis-acting DNA elements, like promoters, silencers and enhancers (1, 4, 5) .
Control regions conferring liver-specific expression in transgenic mice have been shown for example with the human al-antitrypsin (6) , al-glycoprotein (7) and apoCI VLDL (8) genes, and the mouse abumin (9) , oa-fetoprotein (10) , angiotensinogen (11) and transthyretin (12) genes. The expression of a transgene is often influenced by its chromosomal position, resulting in highly variable expression that is not related to the transgene copy number. Some examples are known in which the transgene is expressed in a position-independent, copy-number dependent manner (13) (14) (15) (16) . The information for positionindependent, copy-number dependent expression is provided by so-called Locus Control Regions.
We have shown previously that the induction of the apoVLDL II gene in liver is marked by the appearance of DNaselhypersensitive sites (HSS) in the transcribed and flanking regions (17; see Figure 1 ). One set of DNasel HSS is present in the sequence immediately 5' flanking to the gene. Genomic footprinting experiments demonstrated the tissue-specific and estrogen-dependent interaction of transcription factors with the 300-bp promoter region of the gene (18, 19) . The function of this region has been examined by transient gene transfer experiments (20,2 1) . The region contains two estrogen response elements (EREs). In vitro DNasel footprinting and band-shift analysis has yielded a detailed picture of the protein binding sites in the promoter region. In addition to the estrogen receptor, proteins binding to these sites (18, 19) are the ubiquitous COUPtranscription factor (22) and the liver-enriched transcription factors C/EBP (23), DBP (24) and LF-A1 (25) . In addition to the estrogen-inducible sites, constitutive, liver-specific HSS have been mapped, notably at 1.7 kb and 11 kb in front of the gene (17 and unpublished data (30) .
Northern blotting was performed as described by Krumlauf (31) . Northern DNAaseI HSS mapping Nuclei were isolated according to Gorski et al. (34) and resuspended at a DNA concentration of 1 mg/ml in 15 mM Tris pH 7.5, 60 mM KCl, 15 mM NaCl, 0.2 mM EDTA, 0.2 mM EGTA, 0.15 mM spermine, 0.5 mM spermidine. Incubation of the nuclei was according to Philipsen et al (36) . DNAaseI (Worthington) was added to concentrations of 1-8 Ag/ml, and the reaction was started by the addition of MgCl2 to 10 mM and CalCl2 to 1 mM final concentration. The reaction was allowed to proceed for 5 min on ice, and stopped by the addition of 1 vol 50 mM EDTA, 1 % SDS. DNA was isolated, digested with appropriate restriction enzymes and analyzed by Southern blotting.
RESULTS
Transgenic mice containing the apoVLDL II locus Transgenic mice containing the chicken apoVLDL 11 gene locus were generated. The DNA fragments used for micro-injection contained the transcribed region, 400 bp of 3' flanking region and either 16 kb (construct 20V) or 5 kb (construct 9V) of 5' flanking DNA (Figure 1 ). An additional DNA construct (construct 1 1V) was used in which the BamHl/EcoRl fragment between coordinates -12.5 to -10.5, covering the DNaseIhypersensitive site at -11 kb, was cloned in front of construct 9V. The hypersensitive site may represents a site of protein-DNA interaction involved in the regulation of the apoVLDL 11 gene.
Newborn mice were screened by Southern blotting of EcoRIdigested tail DNA, using an apoVLDL 11-specific probe. Three founder transgenic mice (20V17, 20V20 and 20V22) were obtained with construct 20V, two (9V7 and 9V8) with construct 9V and five (1lV5, 1 1V6, 1 V9, 1 lV 13, 1 1V15) with construct 11V. Mice 20V20 and 20V22 were used to generate F1 offspring. For further analysis of the founder mice, EcoRI-digested DNA from at least four tissues (liver, brain, kidney and lung) was hybridized with a chicken apoVLDL II probe and a Thy-I probe as a loading control. Only mouse 1 IV15 showed a different ratio in the transgene versus Thy-I control signal in the various tissues and this is therefore the only mosaic animal in these experiments. bMouse lIV15 is mosaic.
The integrity of the integrated DNA was checked by Southern blotting; no rearrangements had occurred during chromosomal integration (data not shown). The constructs were inserted as multimers in a head-to-tail configuration into single locations of the mouse genome. The sites of chromosomal integration differed between the mice, as could also be concluded from restriction analysis. VLDL copy-numbers estimated with a Phosphor-Imager using the Thy-l single-copy gene as a reference varied from 2 to 27 and are compiled in Table I .
The chicken apoVLDL II mRNA is correctly processed in the transgenic mouse liver
To establish whether the correct transcription initiation sites of the chicken apoVLDL II gene are used in mouse, total RNA from the livers of estrogen-treated transgenic mice was analyzed by primer extension. Chicken liver RNAs from adult females and estrogen-treated males were used as positive controls. Using an exon-1 specific primer, three different extension products ( Figure 2) were found corresponding to the major start site (nominated +1) and two minor start sites (-11 and + 7) described earlier (36) . The start sites used in chicken (lanes 2 and 3) are also used in the transgenic mice (lanes 1 and 5-7).
To investigate whether the proper polyadenylation site is used in the mouse liver, we performed S1 nuclease protection experiments. The results show that the chicken apoVLDL II transcript has the correct 3' terminus in transgenic mice ( Figure 3) . Furthermore, the mature transcripts in transgenic mice and chicken appear to be of the same length on Northern blots ( Figure 4A ), indicating that the apoVLDL II mRNA is correctly spliced in transgenic mice. Apparently, the avian signals for initation, poly-A addition and processing are faihfullly recognized by mammals.
Liver-specifi'c and estrogen-inducible apoVLDL H gene expression in transgenic mice Quantification of the apoVLDL II gene expression in the livers of transgenic mice by S1 nuclease protection experiments ( Figure 3) showed that construct 20V is expressed to similar levels as the mouse 3-actin gene, which means that the transgene is expressed at high level. Compared to chicken liver where the apoVLDL II transcript forms about 10 % of the total mRNA (2) apoVLDL II expression in mouse liver is 30-fold lower. The expression of the chicken apoVLDL II gene in mouse liver proved to be dependent on estrogen as is the case in the chicken liver. This became clear when comparing a three-week-old, sixgene-copy transgenic mouse, 2OV20b ( Figure 3, lane 8) , that had been injected with estradiol, to its age-matched hormone-naive sister 20V20b(-) (lane 9) in a S1 nuclease protection experiment. At the age of 3 weeks, female mice are not yet in the estruscycle (37). The hormone enhanced the level of apoVLDL transcripts at least 500-fold. Similar results were obtained with male mice. The estrogen-dependent expression was also evident from the Northern analysis ( Figure 4B ). Whereas the estrogentreated mouse liver RNA already gave a clear band on a Northern blot after a three-hour exposure, the non-stimulated mouse yielded only a faint signal of the correct size after one-week exposure (data not shown). When the two-gene-copy transgenic male mouse 20V22 was compared with its hormone-naive brother 20V22(-), a four-fold induction was found (Figure 3, lanes 10  and 11) . This much lower induction-factor is due to the relatively high expression level of the transgene in the hormone-naive mouse, which is probably caused by positive chromosomal position effects. The gene may have been integrated into a chromatin locus with an open conformation, allowing a substantial level of basal transcription. Steroid receptors are believed to act in two different ways, either by a de-repression mechanism involving chromatin opening or by a direct activation/enhancing mechanism accelerating the formation of the transcription complex at the promoter. The four-fold induction by estrogen of the two-copy transgene may represent the activator/enhancer activity of the estrogen receptor. (18, 19, 21, 38, 39) .
When total RNA from different transgenic tissues (ovary plus oviduct, uterus, testis, speen, kidney, brain, thymus, heart, lung and small intestine) were examined ( Figure 4A and data not shown), no transcripts were detectable even after one week of exposure. In summary, the apoVLDL II transgene expression is liver specific, estrogen-inducible, and occurs at high level.
Sequences required to confine expression to the liver In all the apoVLDL II transgenic mice analyzed, the transgene was expressed, and expression was always higher in the liver than in the other tissues. The transgenic mice containing the smaller apoVLDL II construct (9V) from which the -16 kb to -5 kb region was lacking, gave a different tissue pattern of expression. Examination of total RNA from various tissues revealed that the tissue-specificity had been lost. Transgene transcripts were, in addition to liver, detectable in kidney, ovary plus oviduct, lung, uterus, thymus and heart ( Figure 4C , and data not shown).
Transgenic mice containing construct ViI (carrying the -1 1 kb HSS), gave similar results. On longer exposures, ectopic expression is found in kidney, uterus (Fig. 4D) , thymus (mouse 1 IV15; not shown) and heart (mice 1 1V5 and 1 1V6; not shown). This indicates that the addition of the -11 kb HSS is not sufficient to restore tissue specificity and we conclude that other upstream sequences may be required to restrict expression to the liver. DNAsel HSS mapping of the apoVLDL II transgene in mice In chicken, constitutive DNasel HSS were found at -11 kb and -1,7 kb and estrogen-inducible HSS at -8 kb and in the promoter region (17 and unpublished data). These HSS are present in liver but not in kidney. In the present study, we examined the HSS in the livers of hormone-treated and hormonenaive transgenic mice 20V20 containing the larger VLDL fragment. EcoRl-or BamHI-fragments of DNA from DNaseItreated nuclei were Southern blotted and hybridized with probes abutting suitable restriction sites.
Viewing from the EcoRI site within the transcribed region (see Fig. 1 ) upstream into the 5' flanking DNA, we detect hypersensitive sites at the promoter and at 1.7 kb in front of the gene ( Figure 5A ). These sites co-localize with the hypersensitive sites in chicken (17) . The hypersensitivity of the -1.7 region in mice was constitutive as it is in chicken. However, for the promoter region we observe a notable difference between chicken and mice. In non-stimulated rooster liver this region did not contain hypersensitive sites, implying that protein-DNA interactions at the promoter do not occur prior to hormone administration, a conclusion which has been directly corroborated by genomic footprinting (18, 19 tissues where the gene is normally not transcribed. In addition, these far-upstream sequences contain a negative regulating element which map at hypersensitive sites at 11 kb in front of the gene. The correct initiation and poly-adenylation of the apoVLDL II transcript in the livers of transgenic mice implies that the cis-acting DNA elements and trans-acting factors are largely conserved between chicken and mouse. The result is in agreement with the proper expression in transgenic mice of the chicken lysozyme (13) and ,3-globin genes (16) in macrophages and erythropoietic cells, respectively.
Expression of transgenes is often influenced by the regulatory elements present in the mouse genome near the site of integration. This results in a highly variable level of transcription which does not correlate with the gene copy number and often shows a more or less promiscuous tissue pattern of expression. Tissue-specific, position-independent, copy-number dependent expression of transgenes has been obtained with the human (-globin (15) and CD2 genes (14) , and the chicken lysozyme (13) and ,B-globin genes (16) . In these examples, chromosomal position effects are overruled by Locus Control Regions. ApoVLDL II gene expression in our transgenic mice did not follow copy number, but appeared to reach a certain final level for each particular construct. From this we conclude that the position effects of mouse sequences at the site of integration are relatively minor. Our results show that the information for high expression in liver resides in a 9-kb DNA segment extending from 5 kb 5' flanking to the transcribed region to 0.4 kb 3' flanking to the gene. A putative candidate for this specific activity is the constitutive HSS at -1.7 kb where we find genomic DMS and DNasel footprints in liver and oviduct compared with erythrocytes around -1935 and -1831 (18, 19 ; unpublished data). Other candidates are the hormone-inducible DNasel HSS at the promoter region and in the third intron (17) .
In this report, it is shown that the far-upstream region contains a Negative Regulating Element at -11 kb. This situation is somewhat resembling the situation in the 5' flanking region of the chicken lysozyme gene, where upstream NRE's downregulate the expression of the gene (39) . The following question arises: What physiological role may the NRE have? High expression levels of the gene might, like the human apoCi VLDL gene in transgenic mice, give rise to a form of hypertriglyceridemia (8) . The apoVLDL gene would need some kind of modulation to prevent overexpression, and the NRE at -11 kb might be used to reduce the expression after the removal of the inducing stimulus.
